1.Langerhans Cell Sarcoma Arising from Langerhans Cell Histiocytosis: A Case Report.
Jong Sil LEE ; Gyung Hyuck KO ; Ho Cheol KIM ; In Seok JANG ; Kyung Nyeo JEON ; Jeong Hee LEE
Journal of Korean Medical Science 2006;21(3):577-580
Langerhans cell sarcoma (LCS) is a neoplastic proliferation of Langerhans cells that have overtly malignant cytologic features. It is a very rare disease and theoretically, it can present de novo or progress from an antecedent Langerhans cell histiocytosis (LCH). However, to our knowledge, LCS arising from an antecedent LCH has not been reported on. We present here a case of LCS arising from a pulmonary LCH. A 34 yr-old man who was a smoker, had a fever and a chronic cough. Computed tomographic (CT) scan revealed multiple tiny nodules in both lungs. The thoracoscopic lung biopsy revealed LCH. The patient quit smoking, but he received no other specific treatment. One year later, the follow up chest CT scan showed a 4 cm-sized mass in the left lower lobe of the lung. A lobectomy was then performed. Microscopic examination of the mass revealed an infiltrative proliferation of large cells that had malignant cytologic features. Immunohistochemical stains showed a strong reactivity for S-100 and CD68, and a focal reactivity for CD1a. We think this is the first case of LCS arising from LCH.
Tomography, X-Ray Computed
;
Sarcoma/*pathology
;
S100 Proteins/biosynthesis
;
Radiography, Thoracic
;
Pancreatic Neoplasms/*pathology
;
Male
;
Langerhans Cells/*pathology
;
Immunohistochemistry
;
Humans
;
Histiocytosis, Langerhans-Cell/diagnosis/*pathology
;
Gene Expression Regulation, Neoplastic
;
Antigens, Differentiation, Myelomonocytic/biosynthesis
;
Antigens, CD1/biosynthesis
;
Antigens, CD/biosynthesis
;
Adult
2.CD4+CD56+CD68+Hematopoietic Tumor of Probable Plasmacytoid Monocyte Derivation with Weak Expression of Cytoplasmic CD3.
Young Hyeh KO ; Sun Hee KIM ; Keun Chil PARK ; Howe Jung REE
Journal of Korean Medical Science 2002;17(6):833-839
Hematopoietic neoplasm coexpressing CD4 and CD56 includes a subset of acute myeloid leukemia with myelomonocytic differentiation, plasmacytoid monocyte tumor, and other immature hematopoietic neoplasms of undefined origin. Herein, we report a CD4+CD56+CD68+ hematopoietic tumor that was thought to be a tumor of plasmacytoid monocytes. This case is unique in the absence of accompanying myelomonocytic leukemia and the faint expression of cCD3 on the tumor cells. The patient was a 22-yr old man presented with multiple lymphadenopathy and an involvement of the bone marrow. Tumor cells were large and monomorphic with an angulated eosinophilic cytoplasm of moderate amount. Nuclei of most tumor cells were eccentric and round with one or two prominent nucleoli. Rough endoplasmic reticulum was prominent in electron microscopic examination. Tumor cells expressed CD4, CD7, CD10, CD45RB, CD56, CD68, and HLA-DR and were negative for CD1a, CD2, sCD3, CD5, CD13, CD14, CD20, CD33, CD34, CD43, CD45RA, TIA-1, S-100, and TdT. cCD3 was not detected in the immunostaining using paraffin tissue, but was faintly expressed in flow cytometry and immunostaining using a touch imprint slide. T-cell receptor gene rearrangement analysis and EBV in situ hybridization showed negative results. Cytochemically, myeloperoxidase, Sudan black B, and alpha naphthyl butyrate esterase were all negative.
Adult
;
Antigens, CD/*biosynthesis
;
Antigens, CD3/*biosynthesis
;
Antigens, CD4/*biosynthesis
;
Antigens, CD45/biosynthesis
;
Antigens, CD56/*biosynthesis
;
Antigens, Differentiation, Myelomonocytic/*biosynthesis
;
Bone Marrow Cells/pathology
;
Cell Nucleus/pathology
;
Eosinophils/metabolism
;
Flow Cytometry
;
Gene Rearrangement
;
Humans
;
Immunohistochemistry
;
In Situ Hybridization
;
Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis/*metabolism
;
Lymph Nodes/pathology
;
Male
;
Microscopy, Electron
;
Monocytes/*metabolism
;
Receptors, Antigen, T-Cell/metabolism
3.Immunologic classification used in typing of 68 cases of acute leukemias.
Xiu-Li SUN ; Mei-Yun FANG ; Feng JIANG ; Yuan JING
Journal of Experimental Hematology 2006;14(1):39-41
To evaluate the significance of immunologic classification for typing of acute leukemia (AL). 68 cases of AL were classified by morphologic and immunologic typings. The results showed that the consistency rate was 94.1% between morphology and immunology, and 4 morphologic misdiagnosed cases were corrected by immunology; CD13 and CD33 were special myeloid lineage-associated antigens; AML-M(3) was often CD34 low-expressed and HLA-DR-negative; CD14 was often expressed in AML-M(4) and M(5); lymphoid lineage-associated antigens (CD7) were easily found in ANLL, and myeloid lineage-associated antigens were also found in ALL. In conclusion, immunologic classification can improve the accuracy in acute leukemia diagnosis. The diagnosis of some special AL, such as acute unidentified leukemia (AUL), AML-M(0) and so on, must rely on immunologic classification.
Adolescent
;
Adult
;
Aged
;
Antigens, CD
;
biosynthesis
;
Antigens, CD34
;
biosynthesis
;
Antigens, CD7
;
biosynthesis
;
Antigens, Differentiation, Myelomonocytic
;
biosynthesis
;
CD13 Antigens
;
biosynthesis
;
Female
;
Humans
;
Immunophenotyping
;
Leukemia, Myeloid, Acute
;
classification
;
immunology
;
Lipopolysaccharide Receptors
;
biosynthesis
;
Male
;
Middle Aged
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
classification
;
immunology
;
Sialic Acid Binding Ig-like Lectin 3
4.Relationship between macrophages and apoptosis in patients with myelodysplastic syndromes.
Xiao LI ; Shao-xu YING ; Yi-zhi LIU ; Ying TAO ; Chun-kang CHANG ; Qin-yan JIANG ; Wei HUANG ; Jun SHI ; Quan PU
Chinese Journal of Pathology 2003;32(3):226-229
OBJECTIVETo observe the relationship between macrophage proliferation and cell apoptosis in patients with myelodysplastic syndromes (MDS).
METHODSA double labelling method of immunohistochemistry (alkaline phosphatase anti-alkaline phosphatase, APAAP) and ISEL (DNA in situ end labelling) was used to detect the positive CD68 expression (macrophages) and apoptosis on cold plastic embedded bone marrow biopsy sections in 30 MDS cases. 12 cases of iron deficient diseases (IDA) were used as the control.
RESULTS(1) The number of CD68 positive cells in MDS were higher than that in controls (29.2 +/- 33.0/mm(2) bone marrow tissue vs 21.2 +/- 16.7/mm(2)) (P > 0.05); (2) The number of apoptotic cells in MDS group was much higher than that in the controls (71.5 +/- 70.9/mm(2) vs 37.3 +/- 23.0/mm(2), P < 0.05); (3) The number of CD68 expression (35.5 +/- 37.0/mm(2)) and apoptosis (90.7 +/- 74.6/mm(2)) in less advanced MDS were much higher than that in advanced MDS group (14.6 +/- 11.7/mm(2) and 26.8 +/- 33.1/mm(2), P < 0.05 and < 0.01 respectively); (4) CD68 expression showed an obvious positive correlation to apoptosis in MDS cases (r = 0.83, P < 0.001); (5) CD68 positive cells did not show location correlation to apoptotic cells; (6) CD 68 positive cells in MDS showed simultaneous apoptosis.
CONCLUSIONSOver-apoptosis existed in MDS. Less advanced group has a higher ratio of apoptosis than in advanced group. The correlation between macrophages and apoptosis indicates the participation of TNFalpha in apoptosis-induction during MDS development.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antigens, CD ; analysis ; Antigens, Differentiation, Myelomonocytic ; analysis ; Apoptosis ; Child ; Female ; Humans ; Macrophages ; pathology ; Male ; Middle Aged ; Myelodysplastic Syndromes ; pathology ; Tumor Necrosis Factor-alpha ; biosynthesis
5.Study on the expression of human ERMAP gene in erythropoietic and macrophage differentiation of K562 cells.
Ying-Yi HE ; Xiao-Hong ZHANG ; Tie-Zhen YE ; Zi-Liang WU
Journal of Experimental Hematology 2005;13(4):553-556
In order to investigate the potential of human ERMAP gene in erythroid cell differentiation, K562 cells were induced to erythroid lineage by Ara-C and to macrophage lineage by TPA, human ERMAP mRNA was detected by fluorescent quantitative PCR. The results showed that human ERMAP mRNA increased while K562 cells were induced to erythroid lineage after treatment with Ara-C at 2.5 x 10(-6) mmol/L/L and 1.0 x 10(-6) mmol/L/L. Human ERMAP mRNA not changed while K562 cells were induced to macrophage lineage after treatment with TPA at 2.0 x 10(-6) mmol/L/L and 1.0 x 10(-6) mmol/L/L. It is concluded that human ERMAP gene plays an important role in differentiation and proliferation of erythroid cells.
Antigens, CD
;
analysis
;
Antigens, Differentiation, Myelomonocytic
;
analysis
;
Blood Group Antigens
;
genetics
;
Butyrophilins
;
Cell Differentiation
;
drug effects
;
genetics
;
Cytarabine
;
pharmacology
;
Erythrocytes
;
cytology
;
metabolism
;
ultrastructure
;
Flow Cytometry
;
Gene Expression
;
drug effects
;
Humans
;
K562 Cells
;
Macrophages
;
cytology
;
metabolism
;
ultrastructure
;
Microscopy, Electron
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Receptors, Transferrin
;
analysis
;
Reverse Transcriptase Polymerase Chain Reaction
;
methods
;
Sialic Acid Binding Ig-like Lectin 3
;
Tetradecanoylphorbol Acetate
;
pharmacology
;
Time Factors
6.Establishment of a transplantable human myeloid BALB/c nude mouse model.
Ya-Ming WEI ; Ji-Hong LIN ; Rong XIA ; Jun-Cai LAN
Journal of Experimental Hematology 2005;13(4):596-600
To establish a mouse model bearing transplantable human chronic myeloid leukemia for hematopoietic stem cell transplantation to treat leukemia, 4 - 5-week-old female BALB/c nude mice were given cyclophosphamide 2 mg/mouse at day -2, -1, and then the human chronic myeloid leukemia K562 cells were engrafted into the mice at day 0 by injection via tail vein or peritoneal cavity. PB and BM cells were collected, the CD45, CD13, and CD33 antigens were delected by using FCM, the bcr/abl fusion gene mRNA was examined by RT-PCR. The results showed that transplantable leukemic mice could be yielded from 4 - 5-week-old nude mice either by injection through tail vein or peritoneal cavity when the total number of inoculated tumor cells was more than 2 x 10(5) per mouse, whether being pretreated with 2 mg CTX/mouse or not. The transplanted mice could survive 30 - 60 day with leukemia. In conclusion, the mouse model bearing leukemia can be established by inoculation 2 x 10(5) K562 cells into immunodeficient BALB/c nude mice.
Animals
;
Antigens, CD
;
blood
;
Antigens, Differentiation, Myelomonocytic
;
blood
;
Antineoplastic Agents, Alkylating
;
pharmacology
;
CD13 Antigens
;
blood
;
Cyclophosphamide
;
pharmacology
;
Female
;
Flow Cytometry
;
Fusion Proteins, bcr-abl
;
genetics
;
Gene Expression Regulation, Leukemic
;
drug effects
;
Humans
;
K562 Cells
;
Leukemia, Experimental
;
blood
;
genetics
;
pathology
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
;
blood
;
genetics
;
pathology
;
Mice
;
Mice, Inbred BALB C
;
Mice, Nude
;
Neoplasm Transplantation
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Reverse Transcriptase Polymerase Chain Reaction
;
Sialic Acid Binding Ig-like Lectin 3
;
Transplantation, Heterologous
7.Factors regulating expression of antiapoptosis gene survivin.
Journal of Experimental Hematology 2005;13(6):969-974
To explore the regulation mechanism of survivin gene, the NB4 and HL-60 cells were used in experiments, the cell culture in vitro and cell morphological observation were performed and survivin mRNA expression was detected by semi-quantitative RT-PCR. The results showed that the survivin expression in NB4 cell was positive. By treatment of 1 micromol/L ATRA, cell differentiation antigen CD11b was gradually increased ([chi = 47.002, P = 0.000) and CD33 was gradually decreased (chi = 1.614, P = 0.806) with time. Simultaneously, survivin mRNA expression was down-regulated and the cell cycle was arrested at G(0)-G(1) phase (chi = 58.566, P = 0.000). ATRA could down-regulate the survivin mRNA expression of HL-60 cell, but G-CSF, GM-CSF and PHA could up-regulate the survivin expression of HL-60 cell. The cytokine could regulate survivin expression in gene transcription level. The up-regulation of survivin expression was observed while HL-60 cell was stimulated by PHA. The survivin gene expression could be blocked by the survivin antisense oligonucleotide. The survivin mRNA expression of NB4 cell was inhibited by 100 nmol/L-1000 nmol/L survivin antisense oligonucleotide in a dose-dependent manner. The survivin mRNA expression in the NB4 cell was obviously inhibited in 600 nmol/L survivin AS-ODN groups (38%) while the AS-ODN dose increases, the inhibition rate does not descend, but was not inhibited in the control groups, liposomes groups and ODN groups. After NB4 cell was treated by survivin AS-ODN, the typical morphological changes for the apoptosis emerged in NB4 cell. These changes were not found in control groups. It is concluded that PHA, GM-CSF and G-CSF can up-regulate the survivin gene expression, but survivin AS-ODN and ATRA can down-regulate survivin gene expression. The cell cycle arrest at G(0)-G(1) phase while the survivin gene expression was down-regulated by ATRA. It suggested that the survivin gene expression is very related to cell cycle. The morphological changes of cell apoptosis can be observed when the survivin gene expression of NB4 cell was suppressed.
Antigens, CD
;
analysis
;
Antigens, Differentiation, Myelomonocytic
;
analysis
;
Apoptosis
;
drug effects
;
genetics
;
CD11b Antigen
;
analysis
;
Cell Cycle
;
drug effects
;
Cell Line, Tumor
;
Cell Proliferation
;
drug effects
;
Dose-Response Relationship, Drug
;
Down-Regulation
;
drug effects
;
genetics
;
Flow Cytometry
;
Fluorescent Antibody Technique
;
Gene Expression Regulation, Neoplastic
;
Granulocyte Colony-Stimulating Factor
;
pharmacology
;
Granulocyte-Macrophage Colony-Stimulating Factor
;
pharmacology
;
HL-60 Cells
;
Humans
;
Inhibitor of Apoptosis Proteins
;
Microtubule-Associated Proteins
;
genetics
;
Neoplasm Proteins
;
genetics
;
Oligonucleotides, Antisense
;
genetics
;
pharmacology
;
RNA, Messenger
;
biosynthesis
;
genetics
;
Reverse Transcriptase Polymerase Chain Reaction
;
Sialic Acid Binding Ig-like Lectin 3
;
Tretinoin
;
pharmacology
;
Up-Regulation
;
drug effects
;
genetics